Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia consults on ethics of selling human tissue products

This article was originally published in RAJ Devices

Executive Summary

A committee at the Australian National Health and Medical Research Council has developed a concept paper on the ethical issues surrounding the commercialisation of human tissue products1,2.

You may also be interested in...



Launch Of EU Clinical Trial Portal Moves A Step Closer

An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.

EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines

EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.

UK Explains How To Build COVID-19 Resilience Into Trial Design

The UK Medicines and Healthcare products Regulatory Agency wants clinical trial sponsors to integrate available regulatory flexibilities into normal practice so that their studies can withstand further potential disruptions from the COVID-19 pandemic.

UsernamePublicRestriction

Register

OM005385

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel